Vanda Pharmaceuticals placed its VQW-765 social anxiety disorder program on hold following the Phase 3 trial failure announced on October 14, 2026

552c7ae14

Mental health

Supports emotional wellbeing and psychological resilience through digital tools or professional care access.

3 debates·795 claims·43 news stories

0